Enhanced VDAC-cored VRAC in NE-LNCaP cells points to an involvement of eukaryotic porin in the extrinsic apoptotic pathway

International Journal of Urology

Volumn 16, Issue 8, 2009, Pages 702-

  Thinnes, Friedrich P ^a  

^a Max Planck Gesellshaft ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PORIN; VOLTAGE DEPENDENT ANION CHANNEL;

APOPTOSIS; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; EUKARYOTE; LETTER; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; HUMANS; LYMPH NODES; MALE; NEUROENDOCRINE CELLS; PORINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 68749091395     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02334.x     Document Type: Letter

References (5)

1. Thinnes FP. VDAC-cored CaCC, CF patients best friend - finding novel therapeutics for CF. Mol. Genet. Metab. 2009 97 : 92 3.
2. Elinder F, Akanda N, Tofighi R et al. Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli. Cell Death Differ. 2005 12 : 1134 40.
3. Liu Z, Bengtsson S, Krogh M et al. Somatostatin effects on the proteome of the LNCaP cell line. Int. J. Oncol. 2007 30 : 1173 9.
4. Lemonnier L, Lazarenko R, Shuba Y et al. Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl-current associated with neuroendocrine differentiation of prostate cancer epithelial cells. Endocr. Relat. Cancer 2005 12 : 335 49.
5. Thinnes FP. Human type-1 VDAC, a cisplatin target involved in either apoptotic pathway. Mol. Genet. Metab. 2009 97 : 163.